Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Shandong Boan Biotechnology Company., Limited. Class H ( (HK:6955) ) has shared an update.
Shandong Boan Biotechnology Co., Ltd. announced the results of its annual general meeting held on June 5, 2025. Key resolutions included the approval of the company’s 2024 annual report, the appointment of Mr. Wang Shenghan as an executive director and Mr. Li Shixu as a non-executive director, and the re-appointment of Ernst & Young as the company’s auditor for 2025. Additionally, a general mandate was granted to the board to manage shares, impacting the company’s governance and operational strategies.
More about Shandong Boan Biotechnology Company., Limited. Class H
Shandong Boan Biotechnology Co., Ltd. is a biotechnology company based in China, focusing on the development and commercialization of biopharmaceutical products. The company operates within the high-tech industrial sector, aiming to provide innovative solutions in the biotechnology industry.
Average Trading Volume: 10,580,222
Technical Sentiment Signal: Strong Buy
Current Market Cap: HK$6.48B
Learn more about 6955 stock on TipRanks’ Stock Analysis page.